The chemical class designated as IRG1 Activators encompasses a diverse group of compounds that share the common function of inducing the expression of the immune-responsive gene 1 (IRG1) protein. These molecules are of particular interest due to their ability to engage with and modulate the immune system's metabolic pathways. IRG1 activators can be found in a variety of sources, including natural substances found in plants, synthetic compounds designed to mimic pathogenic components, and even metabolic byproducts. The primary unifying characteristic of these activators is their capacity to stimulate the cellular mechanisms that lead to the upregulation of IRG1, a key player in the immune response to environmental challenges. While their structures and origins are varied, the outcome of their interaction with immune cells converges on the enhancement of itaconate production, a metabolite significant for its role in immune cell function.
The mechanisms through which IRG1 activators exert their influence are multifaceted and interconnected with the core signaling pathways of immune cells. For instance, some activators function by mimicking the presence of pathogens, engaging toll-like receptors (TLRs) and triggering a defensive cellular response that includes the upregulation of IRG1. Others may interact with cellular pathways that control the transcriptional machinery, leading to increased expression of the IRG1 gene. The actions of these compounds are often associated with alterations in the cellular redox state, modulation of inflammatory responses, and the reprogramming of cellular metabolism. Despite the different molecular pathways they affect, IRG1 activators collectively contribute to the dynamic regulation of immune responses, illustrating the profound impact that small molecules can have on the complex network of immune regulation. Through their interaction with cellular processes, these activators provide valuable insights into the intricate balance between metabolic and immune system dynamics.
VEJA TAMBÉM
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
Induz a ativação de macrófagos e a subsequente produção de citocinas, o que pode levar à regulação positiva de IRG1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Tem efeitos imunomoduladores e pode ativar a sinalização Nrf2, afectando potencialmente a expressão de IRG1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modula a via do NF-κB, que está implicada na expressão de uma vasta gama de genes imuno-responsivos, incluindo possivelmente o IRG1. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
Afecta o metabolismo dos macrófagos e demonstrou ter efeitos anti-inflamatórios, o que poderia indiretamente aumentar a regulação do IRG1. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $154.00 $276.00 $506.00 $1154.00 $19743.00 $32136.00 $69366.00 | 1 | |
Agonista do TLR7 que pode ativar respostas imunitárias, possivelmente regulando positivamente o IRG1 como parte dessa resposta. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
Agonista de TLR7/8 que ativa as respostas imunitárias inatas, aumentando potencialmente a expressão de IRG1. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
Agonista do TLR1/2 que pode desencadear a ativação das células imunitárias, conduzindo potencialmente a um aumento da expressão de IRG1. | ||||||